Steward Partners Investment Advisory’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-709
| Closed | -$688 | – | 3607 |
|
|
2023
Q3 | $688 | Hold |
709
| – | – | ﹤0.01% | 3226 |
|
|
2023
Q2 | $497 | Hold |
709
| – | – | ﹤0.01% | 3191 |
|
|
2023
Q1 | $468 | Hold |
709
| – | – | ﹤0.01% | 3180 |
|
|
2022
Q4 | $1.06K | Sell |
709
-99
| -12% | -$175 | ﹤0.01% | 3119 |
|
|
2022
Q3 | $1K | Sell |
808
-1
| -0.1% | -$3 | ﹤0.01% | 3194 |
|
|
2022
Q2 | $5K | Sell |
809
-22
| -3% | -$199 | ﹤0.01% | 2789 |
|
|
2022
Q1 | $10K | Buy |
831
+22
| +3% | +$238 | ﹤0.01% | 2684 |
|
|
2021
Q4 | $8K | Hold |
809
| – | – | ﹤0.01% | 2700 |
|
|
2021
Q3 | $26K | Buy |
809
+222
| +38% | +$7.2K | ﹤0.01% | 2208 |
|
|
2021
Q2 | $25K | Hold |
587
| – | – | ﹤0.01% | 4735 |
|
|
2021
Q1 | $28.8K | Buy |
587
+138
| +31% | +$7.58K | ﹤0.01% | 2286 |
|
|
2020
Q4 | $16K | Buy |
449
+222
| +98% | +$6.97K | ﹤0.01% | 2145 |
|
|
2020
Q3 | $9K | Hold |
227
| – | – | ﹤0.01% | 2200 |
|
|
2020
Q2 | $10K | Buy |
227
+178
| +363% | +$9.48K | ﹤0.01% | 2058 |
|
|
2020
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 2339 |
|
|
2019
Q4 | $3K | Hold |
49
| – | – | ﹤0.01% | 2391 |
|
|
2019
Q3 | $9K | Hold |
49
| – | – | ﹤0.01% | 2066 |
|
|
2019
Q2 | $13K | Sell |
49
-6
| -11% | -$2.01K | ﹤0.01% | 1885 |
|
|
2019
Q1 | $20K | Hold |
55
| – | – | ﹤0.01% | 790 |
|
|
2018
Q4 | $20K | Hold |
55
| – | – | ﹤0.01% | 768 |
|
|
2018
Q3 | $24K | Hold |
55
| – | – | ﹤0.01% | 1484 |
|
|
2018
Q2 | $20K | Buy |
55
+9
| +20% | +$4.24K | ﹤0.01% | 1478 |
|
|
2018
Q1 | $20K | Hold |
46
| – | – | ﹤0.01% | 1339 |
|
|
2017
Q4 | $26K | Buy |
46
+35
| +318% | +$23.1K | ﹤0.01% | 1035 |
|
|
2017
Q3 | $8K | Hold |
11
| – | – | ﹤0.01% | 1183 |
|
|
2017
Q2 | $9K | Hold |
11
| – | – | ﹤0.01% | 1089 |
|
|
2017
Q1 | $8K | Buy |
+11
| New | +$7.75K | ﹤0.01% | 1014 |
|
Other funds holding FRTX
Steward Partners Investment Advisory's FRTX Position: Q4 2023 in Review
Steward Partners Investment Advisory sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 709 shares — an estimated $688 sold.
Steward Partners Investment Advisory first reported a position in FRTX in Q1 2017 and held it in 27 quarters. The position peaked at $28.8K in Q1 2021. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.
- Steward Partners Investment Advisory reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Steward Partners Investment Advisory sold 709 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $688.
- Steward Partners Investment Advisory first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2017 and held it in 27 quarters.
- Steward Partners Investment Advisory's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $28.8K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.